Skip to main content

Advertisement

Log in

The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resection

  • How-I-Do-It articles
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Portal vein/superior mesenteric vein (PV/SMV) resection during distal pancreatectomy (DP) is often associated with technical difficulties due to the close anatomic relationship between pancreatic head and PV/SMV. In this paper, we present our operative technique and short-term outcomes of DP combined with venous resection (DP-VR) for left-sided pancreatic cancer (PC).

Methods

We reviewed 368 consecutive cases of DP for PC from January 2013 to December 2018 in our institution, and identified 41 patients (11.1%) who had undergone DP-VR. The remaining 327 DP patients (88.9%) were matched to DP-VR using propensity scores in the proportion of 1:2. Demographics, intraoperative details, postoperative complications and the pathological results were compared between the two groups.

Results

Out of the 41 DP-VR cases, in 14 (34.1%) venous resection with primary closure was performed, while the remaining 27 (65.9%) underwent end-to-end anastomosis without graft. A propensity-score-matched analysis revealed that DP-VR caused an increased risk of postoperative bleeding (17.1% vs. 3.7%, P = 0.016) and delayed gastric emptying (9.8% vs. 1.2%, P = 0.042) compared to standard DP. Overall morbidity (46.3% vs. 36.6%, P = 0.332), postoperative pancreatic fistula (31.7% vs. 26.8%, P = 0.672), R0 resection (58.5% vs. 67.1%, P = 0.223), 30-day reoperation (2.4% vs. 3.7%, P = 0.719), and 90-day mortality (0% vs. 2.5%, P = 0.550) were comparable between the two groups. In postoperative computed tomographic scans of 34 patients (82.9%) at a 90-day follow-up, PV/SMV stenosis was suggested in two patients (5.9%).

Conclusion

Despite the higher rates of postoperative bleeding, DP-VR was found to be a feasible and safe surgery with acceptable postoperative morbidity and mortality compared to standard DP for left-sided pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig.1
Fig.2

Similar content being viewed by others

References

  1. Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK et al (2019) Pancreatic adenocarcinoma, Version 1 2019. J Natl Compr Canc Netw 17(3):202–10

    Article  Google Scholar 

  2. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236(3):355–66 (discussion 66-8)

    Article  Google Scholar 

  3. Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J et al (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma–part 3: update on 5-year survival. J Gastrointest Surg 9(9):1191–204 (discussion 204-6)

    Article  Google Scholar 

  4. Peng C, Zhou D, Meng L, Cao Y, Zhang H, Pan Z et al (2019) The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis. BMC Surg 19(1):84

    Article  Google Scholar 

  5. Giovinazzo F, Turri G, Katz MH, Heaton N, Ahmed I (2016) Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg 103(3):179–191

    Article  CAS  Google Scholar 

  6. Miao Y, Jiang K, Cai B, Yin L, Dai C (2017) Artery divestment for artery involved pancreatic cancer: a retrospective study. Pancreatology 17(4):S25–S26

    Google Scholar 

  7. Cai B, Lu Z, Jiang K, Wu J, Gao W, Chen J et al (2018) AB081. P053 survival of unresectable pancreatic cancer patients after artery divestment combined pancreatectomy: a retrospective and propensity score-matched analysis. Ann Pancreat Cancer 1(1):AB081-AB

    Article  Google Scholar 

  8. Hackert T, Strobel O, Michalski CW, Mihaljevic AL, Mehrabi A, Muller-Stich B et al (2017) The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. HPB (Oxford) 19(11):1001–1007

    Article  Google Scholar 

  9. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161(3):584–591

    Article  Google Scholar 

  10. Panwar R, Pal S (2017) The International Study Group of Pancreatic Surgery definition of delayed gastric emptying and the effects of various surgical modifications on the occurrence of delayed gastric emptying after pancreatoduodenectomy. Hepatobiliary Pancreat Dis Int 16(4):353–363

    Article  Google Scholar 

  11. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 142(1):20–25

    Article  Google Scholar 

  12. Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M et al (2014) Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery 156(1):1–14

    Article  Google Scholar 

  13. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196

    Article  Google Scholar 

  14. NCCN clinical practice guidelines in oncology - Pancretic adenocarcinoma. Version 1.2020 — November 26, 2019. https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf

  15. Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA et al (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155(6):977–988

    Article  Google Scholar 

  16. The Royal College of Pathologists (2002) Standards and mini- mum datasets for reporting cancers. Minimum dataset for the histopathological reporting of pancreatic, ampulla of Vater and bile duct carcinoma. The Royal College of Pathologists, London

  17. Fujisaki S, Tomita R, Fukuzawa M (2001) Utility of mobilization of the right colon and the root of the mesentery for avoiding vein grafting during reconstruction of the portal vein. J Am Coll Surg 193(5):576–578

    Article  CAS  Google Scholar 

  18. de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F et al (2019) Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg 269(1):2–9

    Article  Google Scholar 

  19. Diener MK, Seiler CM, Rossion I, Kleeff J, Glanemann M, Butturini G et al (2011) Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet 377(9776):1514–1522

    Article  Google Scholar 

  20. Hassenpflug M, Hinz U, Strobel O, Volpert J, Knebel P, Diener MK et al (2016) Teres ligament patch reduces relevant morbidity after distal pancreatectomy (the DISCOVER Randomized Controlled Trial). Ann Surg 264(5):723–730

    Article  Google Scholar 

  21. Kondo N, Uemura K, Nakagawa N, Okada K, Kuroda S, Sudo T et al (2019) A multicenter, randomized, controlled trial comparing reinforced staplers with bare staplers during distal pancreatectomy (HiSCO-07 Trial). Ann Surg Oncol 26(5):1519–1527

    Article  Google Scholar 

  22. Van Buren G 2nd, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG et al (2017) A prospective randomized multicenter trial of distal pancreatectomy with and without routine intraperitoneal drainage. Ann Surg 266(3):421–31

    Article  Google Scholar 

  23. van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B et al (2019) Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): a Pan-European propensity score matched study. Ann Surg 269(1):10–17

    Article  Google Scholar 

  24. Miao Y, Lu Z, Yeo CJ, Vollmer CM Jr, Fernandez-Del Castillo C, Ghaneh P et al (2020) Management of the pancreatic transection plane after left (distal) pancreatectomy: expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 168(1):72–84

    Article  Google Scholar 

  25. Dua MM, Tran TB, Klausner J, Hwa KJ, Poultsides GA, Norton JA et al (2015) Pancreatectomy with vein reconstruction: technique matters. HPB (Oxford) 17(9):824–831

    Article  Google Scholar 

  26. Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B et al (2014) Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. J Gastrointest Surg 18(11):2016–2025

    Article  CAS  Google Scholar 

  27. Sgroi MD, Narayan RR, Lane JS, Demirjian A, Kabutey NK, Fujitani RM et al (2015) Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma. J Vasc Surg 61(2):475–480

    Article  Google Scholar 

  28. Huang SS, Liu Y, Jing ZC, Wang XJ, Mao YM (2016) Common genetic risk factors of venous thromboembolism in Western and Asian populations. Genet Mol Res 15(1):15017644

    CAS  PubMed  Google Scholar 

  29. Hiyoshi M, Fujii Y, Kondo K, Imamura N, Nagano M, Ohuchida J (2015) Stent Placement for portal vein stenosis after pancreaticoduodenectomy. World J Surg 39(9):2315–2322

    Article  Google Scholar 

  30. Kim KR, Ko GY, Sung KB, Yoon HK (2011) Percutaneous transhepatic stent placement in the management of portal venous stenosis after curative surgery for pancreatic and biliary neoplasms. AJR Am J Roentgenol 196(4):W446–W450

    Article  Google Scholar 

  31. Zhou ZQ, Lee JH, Song KB, Hwang JW, Kim SC, Lee YJ et al (2014) Clinical usefulness of portal venous stent in hepatobiliary pancreatic cancers. ANZ J Surg 84(5):346–352

    Article  Google Scholar 

  32. Strasberg SM, Drebin JA, Linehan D (2003) Radical antegrade modular pancreatosplenectomy. Surgery 133(5):521–527

    Article  Google Scholar 

  33. Jang JY, Han Y, Lee H, Kim SW, Kwon W, Lee KH et al (2018) Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial. Ann Surg 268(2):215–222

    Article  Google Scholar 

  34. Murphy JE, Wo JY, Ryan DP, Jiang W, Yeap BY, Drapek LC et al (2018) Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial. JAMA Oncol 4(7):963–969

    Article  Google Scholar 

  35. Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG et al (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105(8):946–958

    Article  CAS  Google Scholar 

  36. Lee JH, Kang CM, Bang SM, Choi JY, Seong JS, Hwang HK et al (2015) The Role of neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic cancer with isolated venous vascular involvement. Medicine (Baltimore) 94(31):e1233

    Article  CAS  Google Scholar 

  37. Giulianotti PC, Addeo P, Buchs NC, Ayloo SM, Bianco FM (2011) Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors. Pancreas 40(8):1264–1270

    Article  Google Scholar 

Download references

Funding

This study was funded by the National Natural Science Foundation of China (grant number 82072706/ 81871980); the National Science Foundation for Young Scientists of China (grant number 81703301).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zipeng Lu or Kuirong Jiang.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare no competing interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, D., Wu, P., Zhang, K. et al. The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resection. Langenbecks Arch Surg 407, 2161–2168 (2022). https://doi.org/10.1007/s00423-021-02382-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02382-8

Keywords

Navigation